60 related articles for article (PubMed ID: 7630023)
1. Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?
Li YY; Zhang LY; Xiang YH; Li D; Zhang J
Front Oncol; 2023; 13():1127407. PubMed ID: 37823051
[TBL] [Abstract][Full Text] [Related]
2. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
3. 3,4-Dihydroxybenzalactone Suppresses Human Non-Small Cell Lung Carcinoma Cells Metastasis via Suppression of Epithelial to Mesenchymal Transition, ROS-Mediated PI3K/AKT/MAPK/MMP and NFκB Signaling Pathways.
Chao W; Deng JS; Li PY; Liang YC; Huang GJ
Molecules; 2017 Mar; 22(4):. PubMed ID: 28350337
[TBL] [Abstract][Full Text] [Related]
4. Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness.
Li X; Li P; Liu C; Ren Y; Tang X; Wang K; He J
Oncotarget; 2017 Feb; 8(8):13560-13574. PubMed ID: 28088791
[TBL] [Abstract][Full Text] [Related]
5. The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action.
Yang CM; Liu YZ; Liao JW; Hu ML
Clin Exp Metastasis; 2010 May; 27(5):341-9. PubMed ID: 20449639
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis in human breast cancer.
Garbett EA; Reed MW; Stephenson TJ; Brown NJ
Mol Pathol; 2000 Apr; 53(2):99-106. PubMed ID: 10889910
[TBL] [Abstract][Full Text] [Related]
7. Complex roles of tissue inhibitors of metalloproteinases in cancer.
Jiang Y; Goldberg ID; Shi YE
Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biology of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and the regulation of these genes in tumor tissues].
Takino T; Sato H; Seiki M
Nihon Rinsho; 1995 Jul; 53(7):1791-7. PubMed ID: 7630021
[TBL] [Abstract][Full Text] [Related]
9. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y
Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
13. [The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].
Iwata H; Kobayashi S; Iwase H; Okada Y
Nihon Rinsho; 1995 Jul; 53(7):1805-10. PubMed ID: 7630023
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
